Patents by Inventor Santosh Muddana

Santosh Muddana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210322470
    Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a cross-linking agent and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat an ophthalmic condition by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Applicant: University of Utah Research Foundation
    Inventors: Balamurali K. Ambati, Hironori Uehara, Santosh Muddana
  • Patent number: 11065275
    Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a cross-linking agent and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat an ophthalmic condition by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: July 20, 2021
    Assignee: University of Utah Research Foundation
    Inventors: Balamurali K. Ambati, Hironori Uehara, Santosh Muddana
  • Publication number: 20190083529
    Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a cross-linking agent and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat an ophthalmic condition by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
    Type: Application
    Filed: December 6, 2016
    Publication date: March 21, 2019
    Applicant: University of Utah Research Foundation
    Inventors: Balamurali K. Ambati, Hironori Uehara, Santosh Muddana
  • Publication number: 20190008837
    Abstract: Ophthalmic formulations and compositions employing pergolide to treat an ophthalmic or ocular condition are disclosed and described.
    Type: Application
    Filed: December 15, 2017
    Publication date: January 10, 2019
    Applicant: University of Utah Research Foundation
    Inventors: Balamurali K. Ambati, Santosh Muddana, Xiaohaui Zhang